Crossmark

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2022.09.009

Published Online: 2025-03-10

Published Print: 2023-07-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Savi, D.

Gramegna, A.

Vicenzi, M.

Di Paolo, M.

Messore, B.

Palange, P.

Blasi, F. https://orcid.org/0000-0002-2285-9970
License Information

Version of Record valid from 2023-07-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2022-07-21

Accepted: 2022-09-24

Published: 2025-03-10